Abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

Abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

Abstract Background Dual antiplatelet therapy (DAPT), combining aspirin and a P2Y12 receptor inhibitor, is a standard post-percutaneous coronary intervention (PCI) treatment to reduce thrombosis and ischemic events. However, the optimal DAPT duration remains unclear, with concerns about bleeding ris...

Full description

Saved in:
Bibliographic Details
Main Authors: Hamidreza Soleimani, Elaheh Karimi, Mehrdad Mahalleh, Fatemeh Jodeiri Entezari, Ali Nasrollahizadeh, Amir Nasrollahizadeh, Hamed Rafiee, Parvin Kalhor, Karim M. Al-Azizi, Luis H. Paz Rios, Wilbert S. Aronow, Andrew P. Ambrosy, Kaveh Hosseini
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Acute coronary syndrome
Dual antiplatelet therapy
P2Y12 receptor inhibitor
Percutaneous coronary intervention
Online Access:https://doi.org/10.1186/s12872-025-04765-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12872-025-04765-x

Similar Items